These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30219767)

  • 1. Perceptions of Patients, Caregivers, and Healthcare Providers of Idiopathic Inflammatory Myopathies: An International OMERACT Study.
    Mecoli CA; Park JK; Alexanderson H; Regardt M; Needham M; de Groot I; Sarver C; Lundberg IE; Shea B; de Visser M; Song YW; Bingham CO; Christopher-Stine L
    J Rheumatol; 2019 Jan; 46(1):106-111. PubMed ID: 30219767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advancing the Development of Patient-reported Outcomes for Adult Myositis at OMERACT 2016: An International Delphi Study.
    Park JK; Mecoli CA; Alexanderson H; Regardt M; Christopher-Stine L; Casal-Domínguez M; de Groot I; Sarver C; Lundberg IE; Bingham CO; Song YW
    J Rheumatol; 2017 Nov; 44(11):1683-1687. PubMed ID: 28765245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-reported outcomes and adult patients' disease experience in the idiopathic inflammatory myopathies. report from the OMERACT 11 Myositis Special Interest Group.
    Alexanderson H; Del Grande M; Bingham CO; Orbai AM; Sarver C; Clegg-Smith K; Lundberg IE; Song YW; Christopher-Stine L
    J Rheumatol; 2014 Mar; 41(3):581-92. PubMed ID: 24429182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construct validity of PROMIS pain interference, fatigue, and physical function as patient-reported outcomes in adults with idiopathic inflammatory myopathies: An international study from the OMERACT myositis working group.
    Romich E; Saygin D; DiRenzo D; Mecoli CA; de Groot I; Lodin K; Regardt M; Sarver C; Kim JY; Park JK; Beer K; Needham M; Alexanderson H; Christopher-Stine L; de Visser M; Raaphorst J;
    Semin Arthritis Rheum; 2024 Oct; 68():152534. PubMed ID: 39159576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the content validity of patient-reported outcome measures in adult myositis: A report from the OMERACT myositis working group.
    Esfandiary T; Park JK; Alexanderson H; Regardt M; Needham M; de Groot I; Sarver C; Lundberg IE; de Visser M; Song YW; DiRenzo D; Bingham CO; Christopher-Stine L; Mecoli CA
    Semin Arthritis Rheum; 2020 Oct; 50(5):943-948. PubMed ID: 32906029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responsiveness and meaningful thresholds of PROMIS pain interference, fatigue, and physical function forms in adults with idiopathic inflammatory myopathies: Report from the OMERACT Myositis Working Group.
    Saygin D; DiRenzo D; Raaphorst J; de Groot I; Bingham CO; Lundberg IE; Regardt M; Sarver C; de Visser M; Maxwell LJ; Beaton D; Kim JY; Needham M; Alexanderson H; Christopher-Stine L; Mecoli CA; Park JK;
    Semin Arthritis Rheum; 2024 Feb; 64():152339. PubMed ID: 38141522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients' Experience of Myositis and Further Validation of a Myositis-specific Patient Reported Outcome Measure - Establishing Core Domains and Expanding Patient Input on Clinical Assessment in Myositis. Report from OMERACT 12.
    Regardt M; Basharat P; Christopher-Stine L; Sarver C; Björn A; Lundberg IE; Wook Song Y; Bingham CO; Alexanderson H
    J Rheumatol; 2015 Dec; 42(12):2492-5. PubMed ID: 25934817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OMERACT 2018 Modified Patient-reported Outcome Domain Core Set in the Life Impact Area for Adult Idiopathic Inflammatory Myopathies.
    Regardt M; Mecoli CA; Park JK; de Groot I; Sarver C; Needham M; de Visser M; Shea B; Bingham CO; Lundberg IE; Song YW; Christopher-Stine L; Alexanderson H
    J Rheumatol; 2019 Oct; 46(10):1351-1354. PubMed ID: 30770504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of pain on daily activities in patients with idiopathic inflammatory myopathies: Report from the OMERACT myositis working group.
    Saygin D; Alexanderson H; DiRenzo D; Raaphorst J; de Visser M; Ren D; Regardt M; de Groot I; Sarver C; Kim JY; Lodin K; Beer K; Needham M; Park JK; Christopher-Stine L; Mecoli CA
    Semin Arthritis Rheum; 2024 Aug; 67():152476. PubMed ID: 38851171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in idiopathic inflammatory myopathies: cross-sectional data from the German National Database.
    Albrecht K; Huscher D; Callhoff J; Richter JG; Alexander T; Henes J; Zink A
    Rheumatol Int; 2020 Oct; 40(10):1639-1647. PubMed ID: 32594219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-Reported Outcomes in Adult Idiopathic Inflammatory Myopathies.
    DiRenzo D; Bingham CO; Mecoli CA
    Curr Rheumatol Rep; 2019 Nov; 21(11):62. PubMed ID: 31741079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishing an Updated Core Domain Set for Studies in Juvenile Idiopathic Arthritis: A Report from the OMERACT 2018 JIA Workshop.
    Morgan EM; Munro JE; Horonjeff J; Horgan B; Shea B; Feldman BM; Clairman H; Bingham CO; Thornhill S; Strand V; Alongi A; Magni-Manzoni S; van Rossum MAJ; Vesely R; Vojinovic J; Brunner HI; Harris JG; Horton DB; Lovell DJ; Mannion M; Rahimi H; Ravelli A; Ringold S; Ruperto N; Schrandt MS; Shenoi S; Shiff NJ; Toupin-April K; Tzaribachev N; Weiss P; Consolaro A
    J Rheumatol; 2019 Aug; 46(8):1006-1013. PubMed ID: 30770499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups.
    Lundberg IE; Tjärnlund A; Bottai M; Werth VP; Pilkington C; de Visser M; Alfredsson L; Amato AA; Barohn RJ; Liang MH; Singh JA; Aggarwal R; Arnardottir S; Chinoy H; Cooper RG; Dankó K; Dimachkie MM; Feldman BM; Garcia-De La Torre I; Gordon P; Hayashi T; Katz JD; Kohsaka H; Lachenbruch PA; Lang BA; Li Y; Oddis CV; Olesinska M; Reed AM; Rutkowska-Sak L; Sanner H; Selva-O'Callaghan A; Song YW; Vencovsky J; Ytterberg SR; Miller FW; Rider LG;
    Arthritis Rheumatol; 2017 Dec; 69(12):2271-2282. PubMed ID: 29106061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proposal for a Candidate Core Set of Fitness and Strength Tests for Patients with Childhood or Adult Idiopathic Inflammatory Myopathies.
    van der Stap DK; Rider LG; Alexanderson H; Huber AM; Gualano B; Gordon P; van der Net J; Mathiesen P; Johnson LG; Ernste FC; Feldman BM; Houghton KM; Singh-Grewal D; Kutzbach AG; Alemo Munters L; Takken T;
    J Rheumatol; 2016 Jan; 43(1):169-76. PubMed ID: 26568594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into the knowledge, attitude and practices for the treatment of idiopathic inflammatory myopathy from a cross-sectional cohort survey of physicians.
    Gupta L; Muhammed H; Naveen R; Kharbanda R; Gangadharan H; Misra DP; Lilleker JB; Chinoy H; Agarwal V
    Rheumatol Int; 2020 Dec; 40(12):2047-2055. PubMed ID: 32880031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward the Development of a Core Set of Outcome Domains to Assess Shared Decision-making Interventions in Rheumatology: Results from an OMERACT Delphi Survey and Consensus Meeting.
    Toupin-April K; Barton J; Fraenkel L; Li LC; Brooks P; De Wit M; Stacey D; Légaré F; Meara A; Shea B; Lyddiatt A; Hofstetter C; Gossec L; Christensen R; Scholte-Voshaar M; Suarez-Almazor ME; Boonen A; Meade T; March L; Pohl C; Jull JE; Sivarajah S; Campbell W; Alten R; Karuranga S; Morgan E; Kaufman J; Hill S; Maxwell LJ; Welch V; Beaton D; El-Miedany Y; Tugwell PS
    J Rheumatol; 2017 Oct; 44(10):1544-1550. PubMed ID: 28765239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome Measures in Rheumatology - Interventions for medication Adherence (OMERACT-Adherence) Core Domain Set for Trials of Interventions for Medication Adherence in Rheumatology: 5 Phase Study Protocol.
    Kelly A; Tong A; Tymms K; March L; Craig JC; De Vera M; Evans V; Hassett G; Toupin-April K; van den Bemt B; Teixeira-Pinto A; Alten R; Bartlett SJ; Campbell W; Dawson T; Gill M; Hebing R; Meara A; Nieuwlaat R; Shaw Y; Singh JA; Suarez-Almazor M; Sumpton D; Wong P; Christensen R; Beaton D; de Wit M; Tugwell P;
    Trials; 2018 Mar; 19(1):204. PubMed ID: 29587864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying dimensions of fatigue in haemodialysis important to patients, caregivers and health professionals: An international survey.
    Ju A; Unruh M; Davison SN; Dapueto J; Dew MA; Fluck R; Germain M; Jassal SV; Obrador G; O'Donoghue D; Howell M; O'Lone E; Shen JI; Craig JC; Tong A;
    Nephrology (Carlton); 2020 Mar; 25(3):239-247. PubMed ID: 31347227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing Consensus-Based Outcome Domains for Trials in Children and Adolescents With CKD: An International Delphi Survey.
    Logeman C; Guha C; Howell M; Hanson CS; Craig JC; Samuel S; Zappitelli M; Matsuda-Abedini M; Dart A; Furth S; Eddy A; Groothoff J; Yap HK; Bockenhauer D; Sinha A; Alexander SI; Goldstein SL; Gipson DS; Michael M; Walker A; Kausman J; Gaillard S; Bacchetta J; Rheault MN; Warady BA; Neu A; Christian M; McTaggart S; Liu I; Teo S; Sautenet B; Gutman T; Carter S; Teixeira-Pinto A; Tong A
    Am J Kidney Dis; 2020 Oct; 76(4):533-545. PubMed ID: 32654889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying core domains to assess flare in rheumatoid arthritis: an OMERACT international patient and provider combined Delphi consensus.
    Bartlett SJ; Hewlett S; Bingham CO; Woodworth TG; Alten R; Pohl C; Choy EH; Sanderson T; Boonen A; Bykerk V; Leong AL; Strand V; Furst DE; Christensen R;
    Ann Rheum Dis; 2012 Nov; 71(11):1855-60. PubMed ID: 22772326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.